CEO Waleed Hassanein and CFO Gerardo Hernandez-Omana provided updates on the company’s strategy, clinical trial planning, and ...
Ocugen, Inc. (NASDAQ:OCGN) is one of the High-Flying Penny Stocks to Buy. On March 11, Ocugen, Inc. (NASDAQ:OCGN) was ...
From Rear Window to Shutter Island, these masterfully crafted thrillers prove why suspense storytelling can trap audiences in ...
Cillian Murphy is officially proves he's the Immortal Man in blockbuster Netflix debut for the Peaky Blinders movie.
But 2026 is already gearing up to be just as exciting. Whether you’re a “Toy Story” fan, or Christopher Nolan’s latest epic ...
Oppenheimer analyst Kostas Biliouris maintained a Buy rating on PepGen Inc. today and set a price target of $15.00. Claim 70% Off TipRanks Premium. Unlock hedge fund-level data an ...
In this article, we will take a look at 11 High Profit Margin Stocks to Buy According to Hedge Funds. US equities fell on ...
As Sinners and One Battle After Another dominate the Oscars, what does the awards success of these films mean for movies at ...
All eyes are on biopharmaceutical firm Ocugen today. The company has scheduled a presentation for 2:00 PM CET on Tuesday, ...
The award-winning director and writer Christopher Nolan has both an older and younger brother who have pursued very different ...
In a report released today, from Wedbush maintained a Buy rating on PepGen Inc., with a price target of $9.00. In addition to Wedbush, PepGen Inc. also received a Buy from Oppenheimer’s Kostas ...
Financial Health Overshadows Clinical Progress The immediate concern for Ocugen is its balance sheet. The company concluded its 2025 fiscal year with a substantial net loss of $67.8 million against ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results